Select Equity Group’s Maravai LifeSciences MRVI Stock Holding History

Select Equity Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,524,793	Closed	-$36.1M	–	185
2022 Q4	$36.1M	Sell	2,524,793 -13,926,045	-85%	-$219M	0.14%	94
2022 Q3	$420M	Sell	16,450,838 -2,664,088	-14%	-$66.8M	1.46%	24
2022 Q2	$543M	Buy	19,114,926 +14,870	+0.1%	+$471K	1.74%	16
2022 Q1	$674M	Sell	19,100,056 -1,442,447	-7%	-$48.4M	2.18%	14
2021 Q4	$861M	Buy	20,542,503 +8,420,492	+69%	+$341M	2.35%	12
2021 Q3	$595M	Buy	12,122,011 +4,277,119	+55%	+$209M	2%	17
2021 Q2	$327M	Buy	7,844,892 +3,242,543	+70%	+$126M	1.12%	31
2021 Q1	$164M	Buy	4,602,349 +3,993,858	+656%	+$132M	0.6%	45
2020 Q4	$17.1M	Buy	+608,491	New	+$16.9M	0.07%	90

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Select Equity Group's MRVI Position: Q1 2023 in Review

Select Equity Group sold out of Maravai LifeSciences (MRVI) in Q1 2023, closing a stake of 2,524,793 shares — an estimated $36.1M sold.

Select Equity Group first reported a position in MRVI in Q4 2020 and held it in 9 quarters. The position peaked at $861M in Q4 2021. 219 funds tracked by Wall St. Rank hold MRVI as of Q1 2023.

Select Equity Group reported no remaining Maravai LifeSciences position as of Q1 2023 after selling out during the quarter.
Select Equity Group sold 2,524,793 Maravai LifeSciences shares in Q1 2023, an estimated $36.1M.
Select Equity Group first reported a position in Maravai LifeSciences in Q4 2020 and held it in 9 quarters.
Select Equity Group's Maravai LifeSciences position peaked at $861M in Q4 2021.
219 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2023.

Based on Select Equity Group's 13F filing for Q1 2023, filed 15 May 2023.